Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOcado Regulatory News (OCDO)

Share Price Information for Ocado (OCDO)

Share Price is delayed by 15 minutes
Get Live Data
199.90    -9.30 (-4.45%)
Bid:
202.20
Ask:
202.40
Spread: 0.20 (0.099%)
Market Cap: £1.66b
OCDO Live PriceLast checked at - London Stock Exchange

Intraday Ocado Share Chart

Directorate Change

14 Jul 2022 10:56

RNS Number : 4922S
Ocado Group PLC
14 July 2022
 

DIRECTORATE CHANGESOCADO GROUP PLC14 July 2022

 

Ocado Group plc

Board Committee Changes

 

Ocado Group plc ("Ocado" or "Company") announces the following changes to the composition of its committees.

Committee composition changes

On the recommendation of the Nomination Committee, the Board has approved the following changes to the composition of the Board committees.

Michael Sherman, Non-Executive Director since October 2020, will become a member of the Audit Committee with effect on 22 July 2022.

Nadia Shouraboura, Non-Executive Director since September 2021, will become a member of the Audit Committee with effect on 22 July 2022.

Emma Lloyd, Non-Executive Director since December 2016, will cease to be a member of the Audit Committee with effect on 22 July 2022. Emma will continue as a member of the Remuneration and Nomination Committees.

Andrew Harrison, who was appointed Designated Non-Executive Director for engagement with the Company's workforce in March 2019, will become the Chair of the Nomination Committee with effect from 22 July 2022. In conjunction with this appointment, the Nomination Committee will change its name to the "People Committee" and will expand its remit to cover people engagement issues for the whole Group. This will provide a greater opportunity for Andrew to further the role of the Group's Designated Non-Executive Director and provide a critical link between the Board and our Ocado workforce. It will also allow the Board to discuss wider workforce views and priorities and help strengthen the employee voice in the Boardroom. Richard Haythornthwaite will cease to be the Chair of the Nomination Committee at the same time, but will continue his membership of the Nomination Committee.

 

The table below confirms the new composition of the committees, following implementation of all the above mentioned changes.

Committee

Composition prior to above mentioned changes

Composition following all the above mentioned changes

Audit Committee

Julie Southern (Chair)

Andrew Harrison

Emma Lloyd

John Martin

Julie Southern (Chair)

Andrew Harrison

John Martin

Michael Sherman

Nadia Shouraboura

Remuneration Committee

Andrew Harrison (Chair)

Julie Southern

Emma Lloyd

Andrew Harrison (Chair)

Julie Southern

Emma Lloyd

Nomination Committee

Richard Haythornthwaite (Chair)

Jörn Rausing

Andrew Harrison

Emma Lloyd

Julie Southern

John Martin

Michael Sherman

Nadia Shouraboura

Andrew Harrison (Chair)

Richard Haythornthwaite

Jörn Rausing

Emma Lloyd

Julie Southern

John Martin

Michael Sherman

Nadia Shouraboura

 

 

The person responsible for arranging the release of this announcement is:

Neill AbramsGroup General Counsel and Company SecretaryOcado Group plcBuildings One & Two Trident PlaceMosquito WayHatfieldHertfordshireAL10 9ULTel: +44 (0)1707 228 000Email: company.secretary@ocado.com

Ocado Group plc LEI: 213800LO8F61YB8MBC74

Notes:

1. As Non-Executive Directors, the newly appointed Audit Committee members, will each be paid a Committee membership fee in line with the Directors' Remuneration Policy. Andrew Harrison, as the newly appointed Nomination Committee chair, will be paid a fee of £20,700 per annum, in line with the Directors' Remuneration Policy. This is the first occasion that such Committee Chair role has been remunerated, but the introduction of such fee, approved by the Board, reflects the newly expanded remit of this Committee.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOASFISULEESEIW
Date   Source Headline
2nd Jun 20261:43 pmRNSDirector/PDMR Shareholding
1st Jun 20263:09 pmRNSTotal Voting Rights
29th May 20267:00 amRNSOcado Group & Asda to enter ecommerce partnership
28th May 20268:11 amRNSDirector Declaration
19th May 20269:26 amRNSDirector/PDMR Shareholding
19th May 20268:33 amRNSAdmission to Trading
1st May 202611:31 amRNSTotal Voting Rights
28th Apr 20263:53 pmRNSResult of AGM
20th Apr 202611:07 amRNSHolding(s) in Company
16th Apr 20264:05 pmRNSDirector/PDMR Shareholding
14th Apr 202611:25 amRNSAdmission to Trading
7th Apr 202612:54 pmRNSDirector/PDMR Shareholding
7th Apr 202610:51 amRNSHolding(s) in Company
1st Apr 202611:24 amRNSTotal Voting Rights
30th Mar 20263:54 pmRNSDirector/PDMR Shareholding
18th Mar 202610:22 amRNSHolding(s) in Company
17th Mar 20264:30 pmRNSDirector/PDMR Shareholding
17th Mar 20268:48 amRNSDirector/PDMR Shareholding
17th Mar 20268:48 amRNSDirector/PDMR Shareholding
13th Mar 20269:50 amRNSHolding(s) in Company
13th Mar 20269:50 amRNSHolding(s) in Company
13th Mar 20269:40 amRNSDirector/PDMR Shareholding
13th Mar 20269:40 amRNSDirector/PDMR Shareholding
5th Mar 202611:00 amRNSAnnual Financial Report and Notice of Meeting
3rd Mar 20262:59 pmRNSDirector/PDMR Shareholding
3rd Mar 20262:56 pmRNSDirector/PDMR Shareholding
2nd Mar 202611:57 amRNSTotal Voting Rights
26th Feb 20267:00 amRNSPreliminary Results
17th Feb 20263:19 pmRNSDirector/PDMR Shareholding
5th Feb 20263:50 pmRNSHolding(s) in Company
5th Feb 20263:23 pmRNSHolding(s) in Company
5th Feb 20268:29 amRNSHolding(s) in Company
3rd Feb 20266:09 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSDirector Declaration
2nd Feb 20264:40 pmRNSTotal Voting Rights
29th Jan 20267:00 amRNSUpdate on Sobeys Partnership
28th Jan 20264:26 pmRNSHolding(s) in Company
27th Jan 20264:57 pmRNSBlock Listing Interim Review
22nd Jan 20263:07 pmRNSHolding(s) in Company
20th Jan 20263:25 pmRNSHolding(s) in Company
16th Jan 20262:06 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNSHolding(s) in Company
9th Jan 20267:00 amRNSHolding(s) in Company
2nd Jan 202610:46 amRNSTotal Voting Rights
30th Dec 20257:00 amRNSExclusivity with International Partners
30th Dec 20257:00 amRNSExclusivity with International Partners
23rd Dec 20254:03 pmRNSHolding(s) in Company
23rd Dec 20254:03 pmRNSHolding(s) in Company
16th Dec 202511:45 amRNSDirector/PDMR Shareholding
9th Dec 202510:23 amRNSRedemption of Convertible Bonds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.